The coronavirus pandemic is a serious health risk, which is why countries around the world are racing to find vaccines and treatments. Nearly 1,000,000 cases of COVID-19 have been confirmed globally, and by the time you read this, the death toll will have surpassed 50,000. Some potential treatments listed here were previously in clinical testing for other diseases, such as cancer, allowing the trials for COVID-19 to be fast-tracked. Many aren’t aimed at the coronavirus itself but instead will hopefully reduce some of the severe side effects the disease causes, like hyperinflammation and respiratory distress. Notably, many of the proposed treatments have gone through U.S. Food and Drug Administration (FDA) approval for other uses or are currently going through that process, meaning the route to getting approved for a clinical trial to study their effects on COVID-19 patients is shorter and faster than it would be for a new drug. Some of these are being utilized under compassionate use rules, meaning they aren’t part of clinical trials but are being administered to COVID-19 patients in life-threatening situations. The path from trial to treatment is long and complex. As new treatments and vaccines make their way to new phases, we’ll update… Read full this story
- Gaming Addiction Has A Potential Viable Treatment!
- Trials Rising Review: The Same But Still Pretty Fun
- FIFA 19 reviews round-up, all the scores
- Madden NFL 19 Audio Stuttering Fix, Game Not Launching, "Dx11Renderer::tryMap" Failed And Fixes
- EA Explains Accidental Reason for Removing Colin Kaepernick's Name from Song in Madden NFL 19
- EA E3 2018: FIFA 19
- Madden NFL 19 censors Colin Kaepernick’s name
- NHS to fund its first internet addiction clinic
- NHS England opens a new clinic for young gaming addicts
- Ched Evans trial: Government considers rape law change
All the COVID-19 vaccines and treatments currently in clinical trials have 286 words, post on www.digitaltrends.com at April 2, 2020. This is cached page on CuBird. If you want remove this page, please contact us.